BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19821969)

  • 1. Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.
    Kaisar MO; Armstrong K; Hawley C; Campbell S; Mudge D; Johnson DW; Prins JB; Isbel NM
    BMC Nephrol; 2009 Oct; 10():29. PubMed ID: 19821969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal adiponectin levels in kidney transplant patients with hypertension.
    Leibowitz A; Peleg E; Ben-David A; Sharabi Y; Kamari Y; Holzman E; Grossman E
    Clin Transplant; 2013; 27(4):562-6. PubMed ID: 23758483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome.
    Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
    Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.
    Adachi H; Nakayama K; Hayashi N; Matsui Y; Fujimoto K; Yamaya H; Tonami H; Yokoyama H
    PLoS One; 2016; 11(10):e0163899. PubMed ID: 27706207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.
    Massy ZA; Chadefaux-Vekemans B; Chevalier A; Bader CA; Drüeke TB; Legendre C; Lacour B; Kamoun P; Kreis H
    Nephrol Dial Transplant; 1994; 9(8):1103-8. PubMed ID: 7800208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure.
    Ocak N; Dirican M; Ersoy A; Sarandol E
    Ren Fail; 2016 Nov; 38(10):1639-1646. PubMed ID: 27764985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal transplant recipients.
    Leberkühne LJ; Ebtehaj S; Dimova LG; Dikkers A; Dullaart RP; Bakker SJ; Tietge UJ
    Atherosclerosis; 2016 Jun; 249():181-5. PubMed ID: 27107804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hepcidin-25 with survival after kidney transplantation.
    Eisenga MF; Dullaart RP; Berger SP; Sloan JH; de Vries AP; Bakker SJ; Gaillard CA
    Eur J Clin Invest; 2016 Dec; 46(12):994-1001. PubMed ID: 27696386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study.
    Roos M; Baumann M; Liu D; Heinemann FM; Lindemann M; Horn PA; Türk T; Lutz J; Heemann U; Witzke O; von Eynatten M
    Regul Pept; 2012 Oct; 178(1-3):11-5. PubMed ID: 22750635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery.
    Sawaguchi T; Nakajima T; Haruyama A; Hasegawa T; Shibasaki I; Nakajima T; Kaneda H; Arikawa T; Obi S; Sakuma M; Ogawa H; Takei Y; Toyoda S; Nakamura F; Abe S; Fukuda H; Inoue T
    PLoS One; 2019; 14(11):e0225008. PubMed ID: 31703113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease.
    Hughes JT; O'Dea K; Piera K; Barzi F; Cass A; Hoy WE; MacIsaac RJ; Maple-Brown LJ
    Obes Res Clin Pract; 2016; 10(6):659-672. PubMed ID: 26669799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous plasma erythropoietin, cardiovascular mortality and all-cause mortality in renal transplant recipients.
    Sinkeler SJ; Zelle DM; Homan van der Heide JJ; Gans RO; Navis G; Bakker SJ
    Am J Transplant; 2012 Feb; 12(2):485-91. PubMed ID: 22054202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D status in renal transplant recipients living in a low-latitude city: association with body fat, cardiovascular risk factors, estimated glomerular filtration rate and proteinuria.
    Rosina KTC; Menna Barreto APM; Pontes KSS; Martins CJM; Souza E; Bregman R; Barreto Silva MI; Klein MRST
    Br J Nutr; 2017 May; 117(9):1279-1290. PubMed ID: 28592350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients.
    El Aggan H; Mahmoud S; El Shair H; Elabd H
    Biomed J; 2021 Dec; 44(6 Suppl 2):S179-S189. PubMed ID: 35300946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease.
    Lo MM; Salisbury S; Scherer PE; Furth SL; Warady BA; Mitsnefes MM
    Pediatr Nephrol; 2011 Nov; 26(11):2009-17. PubMed ID: 21553321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Patel S; Arshad T; Lee E; Albhaisi S; Driscoll C; Wolver S; Reichman T; Bhati C; Siddiqui MS
    Transplantation; 2019 Nov; 103(11):2323-2328. PubMed ID: 30946215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
    Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
    Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.